Trials / Completed
CompletedNCT04486807
Shoulder Muscle Imbalance as a Risk Factor for Shoulder Injury in Elite Badminton Players
Shoulder Muscle Imbalance as a Risk Factor for Shoulder Injury in Elite Adolescent Badminton Players: a Prospective Pilot Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Background: To assess the impact of pre-season clinical measures and rotator muscles strength on the risk of significant shoulder injury (SSI) in elite badminton players Design: Prospective cohort study Participants: Nineteen elite adolescents badminton players were included and followed over the badminton season (from september 2018 to may 2019 and/or from september 2019 to may 2020) . Independent variables: A pre-season visit consisted in clinical and isokinetic shoulder strength testing. Clinical testing consisted in the shoulder range of motion (ROM) measurements and the table-to-acromion distance (TAD)Isokinetic internal and external rotator shoulder muscles strength was tested at 60 and 240°/s. Conventional and functional (eccentric-to-concentric) ratios (FR) were calculated. SSI collection was performed by an experienced sport physician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Elite badminton players | The population was all the elite badminton players followed in a University Hospital Centre and the National Institute of Sport, Expertise, and Performance. We excluded players who had SSI in the 3 months prior to the isokinetic test or had shoulder surgery. They were included and followed during the badminton season (Nineteen elite badminton players and followed over the badminton season (from september 2018 to may 2019 or from september 2019 to may 2020) |
Timeline
- Start date
- 2018-08-05
- Primary completion
- 2018-09-01
- Completion
- 2020-05-15
- First posted
- 2020-07-27
- Last updated
- 2020-07-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04486807. Inclusion in this directory is not an endorsement.